Delivery Order SPE2DB22D1202-SPE2DB25FUSN8
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,491.38, is for the provision of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $1,667.55 firm fixed price contract is for the delivery of Tresiba Flextouch 100 Unit/ML 3ML, a prescription diabetes medication. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tresiba FlexTouch 100 unit/ml 3ml, a medication used for the treatment of diabetes. The contract has a firm fixed price of $4,942.80 and an ultimate completion date of January 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tresiba Flextouch 100 Unit/mL 3mL, a diabetes medication. The contract has a ceiling value of $1,861.80 and a period of performance through November 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.61, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside and is an open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,987.26, is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of February 3, 2025 and is a firm fixed-price agreement. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation for the supply of Tresiba Flextouch 200 Unit/mL 3mL, a prescription medication. The fixed-price contract has a ceiling value of $7,220.33 and a period of performance through August 12, 2024. As a prime contractor, AmerisourceBergen, a major pharmaceutical distributor, will be responsible for delivering the requested pharmaceutical product to support medical treatment...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba Flextouch 200 unit/mL 3mL medication. The $6,169.44 firm fixed-price contract has a completion date of January 31, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This federal contract award, valued at $7,278.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,402.95, is for the procurement of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The contract has an ultimate completion date of December 19, 2023 and is a Firm Fixed Price contract. There is no set-aside designation noted for this award. AmerisourceBergen holds a significant...